LNZA

LanzaTech Global, Inc.

Nasdaq · Industrial Organic Chemicals · Inc. DE · CIK 0001843724
$8.40 -2.78% $87.2M
Vol
Market Cap$87.2M
Cap SizeMicro Cap
Inst. Holders3 funds
Inst. Value$852.7K
Inst. Activity0 buys / 2 sells
SEC Reports1
Press Releases1
Exchange Nasdaq·Sector Industrial Organic Chemicals·Inc. DE·CIK 0001843724·Prev Close $8.64

Recent Activity

Price Targets

Historical data — last covering-analyst action Nov 2025. No current recommendation available.
$15.00 (Nov 2025)
Current $8.40 Low $15.00 Median $15.00 High $15.00 1 analysts
$15.00 $15.00

Analyst Ratings

Historical distribution0% buy · 6 analysts · last covering-analyst action Nov 2025
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Historical Analyst Actions
DateFirmActionRating
Nov 20, 2025 Roth Capital MAINTAIN Neutral → Neutral
Mar 13, 2025 Janney Montgomery Scott DOWNGRADE Buy → Neutral
Nov 11, 2024 TD Cowen MAINTAIN Hold → Hold
May 7, 2024 TD Cowen INITIATE Hold
Mar 25, 2024 Roth MKM MAINTAIN Buy → Buy

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.76 ▲ +62.0% $-0.76 — $-0.76 95% YoY 1
Next Q $-0.81 ▲ +46.4% $-0.81 — $-0.81 86% YoY 1
Current FY $-3.73 ▲ +51.3% $-3.73 — $-3.73 90% YoY 1

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$852.4KNEW
BANK OF AMERICA CORP$179.00NEAR_EXIT
MORGAN STANLEY$55.00NEAR_EXIT
3 institutional holders with $852.7K total value (61,966 shares) as of 2025-Q4. Top holders: VANGUARD, BANK, MORGAN. Net selling activity: 2 institutions trimmed/exited vs 0 added.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC61,949$852.4K100.0%NEW
2BANK OF AMERICA CORP /DE/13$179.000.0%NEAR_EXIT -80.6%
3MORGAN STANLEY4$55.000.0%NEAR_EXIT -98.4%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
BANK OF AMERICA CORP /DE/NEAR_EXIT6713-80.6%$179.002025-Q4
MORGAN STANLEYNEAR_EXIT2534-98.4%$55.002025-Q4
VANGUARD GROUP INCNEW59,169$1.5M2025-Q3
UBS Group AGNEW1,150$28.2K2025-Q3
MORGAN STANLEYEXIT147,4040-100.0%$0.002025-Q3
VANGUARD GROUP INCEXIT5,746,1460-100.0%$0.002025-Q3
CHARLES SCHWAB INVESTMENT MANAGEMENT INCEXIT391,1090-100.0%$0.002025-Q3
UBS Group AGEXIT1,689,3680-100.0%$0.002025-Q3
UBS Group AGDOUBLED835,3291,689,368+102.2%$457.8K2025-Q2
CHARLES SCHWAB INVESTMENT MANAGEMENT INCTRIM653,158391,109-40.1%$106.1K2025-Q2
BANK OF AMERICA CORP /DE/TRIM36,25211,523-68.2%$3.1K2025-Q2
WELLS FARGO & COMPANY/MNNEAR_EXIT57,4135,749-90.0%$1.6K2025-Q2
UBS Group AGDOUBLED343,645835,329+143.1%$202.1K2025-Q1
MORGAN STANLEYTRIM330,189176,393-46.6%$42.7K2025-Q1
CITADEL ADVISORS LLCDOUBLED28,50075,500+164.9%$18.3K2025-Q1
FMR LLCDOUBLED3,73517,969+381.1%$4.3K2025-Q1
UBS Group AGDOUBLED96,529343,645+256.0%$470.8K2024-Q4
WELLS FARGO & COMPANY/MNADD38,43156,235+46.3%$77.0K2024-Q4
CITADEL ADVISORS LLCNEW28,500$39.0K2024-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW756,552$1.4M2024-Q3
MORGAN STANLEYADD240,885390,745+62.2%$746.3K2024-Q3

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

1 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 6.0/10.
Historical analyst distribution (last covering-analyst action Nov 2025): 0% buy across 6 analysts — 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Nov 2025. No current recommendation available.
$15.00 mean target (Nov 2025)
$15.00 Low $15.00 High
MetricValue
Current Price$8.40
Target Low$15.00
Target Mean$15.00
Target Median$15.00
Target High$15.00
# Analysts1
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$-0.76 $-0.76 $-0.76 94.9% +62.0% 1↑ 0↓ $0.0B 44.2% 1
Next Q
2026-09-30
$-0.81 $-0.81 $-0.81 85.9% +46.4% 1↑ 0↓ $0.0B 49.8% 1
Current FY
2026-12-31
$-3.73 $-3.73 $-3.73 89.5% +51.3% 1↑ 0↓ $0.1B -2.9% 1
Next FY
2027-12-31
$0.00 $0.00 $0.00 $0.0B

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.760
7d ago$-2.000+1.240
30d ago$-2.000+1.240
60d ago$0.000-0.760
90d ago$0.000-0.760
5 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 4 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Nov 20, 2025 Roth Capital MAINTAIN Neutral Neutral
Mar 13, 2025 Janney Montgomery Scott DOWNGRADE Buy Neutral
Nov 11, 2024 TD Cowen MAINTAIN Hold Hold
May 7, 2024 TD Cowen INITIATE Hold
Mar 25, 2024 Roth MKM MAINTAIN Buy Buy
Mar 15, 2024 Seaport Global INITIATE Buy
Dec 28, 2023 Janney Montgomery Scott INITIATE Buy
Sep 19, 2023 Roth MKM REITERATE Buy Buy
May 12, 2023 Roth MKM INITIATE Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
May 1, 2026003120%
Apr 1, 2026003120%
Mar 1, 2026003120%
Feb 1, 2026003120%
Jan 1, 2026003120%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 18, 2026
earnings_calendar
LNZA Q1 2026 Earnings Before Market Open — 2026-05-18
May 14, 2026
earnings
LanzaTech Reports First Quarter 2026 Financial Results
Sustained Focus on Execution as Transformation Progresses <pre>Sustained Focus on Execution as Transformation Progresses</pre>
May 11, 2026
other
LanzaTech Selects North Sea Port, Ghent as Site for Europe’s First Commercial Alcohol-to-Jet SAF Facility
€500 Million Project Targets 79 000 Tonnes of Sustainable Aviation Fuel and 9 000 Tonnes of Renewable Diesel Annually <pre>€500 Million Project Target
May 6, 2026
contract
BRIGHT and LanzaTech launch new partnership to accelerate carbon-to-value biotechnology in Europe
A multi-year collaboration will establish a next-generation C1 biofoundry at DTU to convert industrial carbon emissions into fuels, chemicals, and mat
Mar 31, 2026
earnings
LanzaTech Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Continued Focus on Operational Execution and Strategic Transformation <pre>Continued Focus on Operational Execution and Strategic Transformation</pre>
Mar 16, 2026
earnings_calendar
LNZA Q4 2025 Earnings Before Market Open — 2026-03-16